These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 15116243)

  • 1. Thrombosis and nitric oxide donor drugs.
    Maree AO; Cox D
    Thromb Haemost; 2004 May; 91(5):848-50. PubMed ID: 15116243
    [No Abstract]   [Full Text] [Related]  

  • 2. Nitric oxide-enhancing or -releasing agents as antithrombotic drugs.
    Gresele P; Momi S; Guglielmini G
    Biochem Pharmacol; 2019 Aug; 166():300-312. PubMed ID: 31173724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Local administration of nitric oxide donor significantly impacts microvascular thrombosis.
    Chiang S; Azizzadeh B; Buga G; Ignarro L; Calcaterra T; Blackwell K
    Laryngoscope; 2003 Mar; 113(3):406-9. PubMed ID: 12616187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiplatelet therapy with aspirin: from clinical trials to practice.
    Goodnight SH
    Thromb Haemost; 1995 Jul; 74(1):401-5. PubMed ID: 8578495
    [No Abstract]   [Full Text] [Related]  

  • 5. NO-glibenclamide derivatives: prototypes of a new class of nitric oxide-releasing anti-diabetic drugs.
    Calderone V; Rapposelli S; Martelli A; Digiacomo M; Testai L; Torri S; Marchetti P; Breschi MC; Balsamo A
    Bioorg Med Chem; 2009 Aug; 17(15):5426-32. PubMed ID: 19595600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of a novel platelet nitric oxide donor (LA816), aspirin, clopidogrel, and combined therapy in inhibiting flow- and lesion-dependent thrombosis in the porcine ex vivo model.
    Vilahur G; Segalés E; Salas E; Badimon L
    Circulation; 2004 Sep; 110(12):1686-93. PubMed ID: 15381660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacology and potential therapeutic applications of nitric oxide-releasing non-steroidal anti-inflammatory and related nitric oxide-donating drugs.
    Keeble JE; Moore PK
    Br J Pharmacol; 2002 Oct; 137(3):295-310. PubMed ID: 12237248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel anti-ischemic nitric oxide donor inhibits thrombosis without modifying haemodynamic parameters.
    Vilahur G; Segalés E; Casaní L; Badimon L
    Thromb Haemost; 2004 May; 91(5):1035-43. PubMed ID: 15116267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic potential of nitric oxide donors in the prevention and treatment of atherosclerosis.
    Herman AG; Moncada S
    Eur Heart J; 2005 Oct; 26(19):1945-55. PubMed ID: 15911567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The many antithrombotic actions of nitric oxide.
    Tziros C; Freedman JE
    Curr Drug Targets; 2006 Oct; 7(10):1243-51. PubMed ID: 17073585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Endothelial dysfunction and metabolic effects of nitric oxide in human].
    Kolesnichenko OIu; Filatova LM; Krivitsina ZA; Voronkov IuI
    Fiziol Cheloveka; 2003; 29(5):74-81. PubMed ID: 14611088
    [No Abstract]   [Full Text] [Related]  

  • 12. [Anti-thrombotic effect of nitric oxide].
    Hayashi T
    Nihon Rinsho; 2004 Sep; 62 Suppl 9():505-9. PubMed ID: 15506437
    [No Abstract]   [Full Text] [Related]  

  • 13. [Mechanism of nitric oxide production in vascular endothelium and the significance as therapeutic target--special reference to the relationship with superoxides].
    Oike M
    Fukuoka Igaku Zasshi; 2000 Oct; 91(10):256-65. PubMed ID: 11215249
    [No Abstract]   [Full Text] [Related]  

  • 14. Therapeutic role of nitric oxide as emerging molecule.
    Kumar S; Singh RK; Bhardwaj TR
    Biomed Pharmacother; 2017 Jan; 85():182-201. PubMed ID: 27940398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NO-donors, part 9 : diazeniumdiolates inhibit human platelet aggregation and induce a transient vasodilatation of porcine pulmonary arteries in accordance with the NO-releasing rates.
    Abuo-Rahma Gel D; Horstmann A; Radwan MF; El-Emam A; Glusa E; Lehmann J
    Eur J Med Chem; 2005 Mar; 40(3):281-7. PubMed ID: 15725497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Nitric oxide depot in blood vessels in vivo].
    Smirin BV; Vanin AF; Malyshev IIu; Pokidyshev DA; Manukhina EB
    Biull Eksp Biol Med; 1999 Jun; 127(6):629-32. PubMed ID: 10445125
    [No Abstract]   [Full Text] [Related]  

  • 17. Prevention by NCX 4016, a nitric oxide-donating aspirin, but not by aspirin, of the acute endothelial dysfunction induced by exercise in patients with intermittent claudication.
    Gresele P; Migliacci R; Procacci A; De Monte P; Bonizzoni E
    Thromb Haemost; 2007 Mar; 97(3):444-50. PubMed ID: 17334512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of transient endothelial dysfunction in acute exercise: a friendly fire?
    Suvorava T; Kojda G
    Thromb Haemost; 2007 Mar; 97(3):331-3. PubMed ID: 17334496
    [No Abstract]   [Full Text] [Related]  

  • 19. [Nitric oxide. The role of guanylate cyclase in its physiological effects].
    Severina IS
    Vopr Med Khim; 2002; 48(1):4-30. PubMed ID: 12068497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulmonary hypertension, nitric oxide and nitric oxide-releasing compounds.
    Hagan G; Pepke-Zaba J
    Expert Rev Respir Med; 2011 Apr; 5(2):163-71. PubMed ID: 21510727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.